Antimicrobial Resistance Surveillance Market Research Report Information By Solution (Kits, System, Surveillance Software and Service), By Application (Clinical Diagnostics and Public Health Surveillance), By End User (Hospitals, Clinics, Academic and Research Institutes) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION

6.1. Overview

6.2. Kits

6.3. System

6.4. Surveillance Software

6.5. Service

7. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION

7.1. Overview

7.2. Clinical Diagnostics

7.3. Public Health Surveillance

8. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER

8.1. Overview

8.2. Hospitals

8.3. Clinics

8.4. Academic

8.5. Research Institutes

9. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Antimicrobial Resistance Surveillance Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Antimicrobial Resistance Surveillance Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Thermo Fisher Scientific Inc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. BioMérieux SA

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Becton, Dickinson and Company

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Danaher Corporation

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Roche Diagnostics International Ltd.

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Siemens Healthineers

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Bruker Corporation

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Agilent Technologies, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Abbott Laboratories

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Cepheid Inc.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 US: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 10 US: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 11 US: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 12 CANADA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 13 CANADA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 CANADA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 10 ITALY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 11 ITALY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 ITALY: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 16 UK: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 17 UK: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 UK: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 28 CHINA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 29 CHINA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 30 CHINA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 31 INDIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 32 INDIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 33 INDIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY SOLUTION, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET

FIGURE 4 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY SOLUTION, 2023

FIGURE 5 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 6 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY END USER, 2023

FIGURE 7 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 15 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 BIOMÉRIEUX SA: SWOT ANALYSIS

FIGURE 17 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS

FIGURE 19 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 DANAHER CORPORATION: SWOT ANALYSIS

FIGURE 21 ROCHE DIAGNOSTICS INTERNATIONAL LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 ROCHE DIAGNOSTICS INTERNATIONAL LTD.: SWOT ANALYSIS

FIGURE 23 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 SIEMENS HEALTHINEERS: SWOT ANALYSIS

FIGURE 25 BRUKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 BRUKER CORPORATION: SWOT ANALYSIS

FIGURE 27 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS

FIGURE 29 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ABBOTT LABORATORIES: SWOT ANALYSIS

FIGURE 31 CEPHEID INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 CEPHEID INC.: SWOT ANALYSIS